Do plasma melatonin concentrations decline with age?

American Journal of Medicine

Volumn 107, Issue 5, 1999, Pages 432-436

  Zeitzer, Jamie M ^a,b   Daniels, Jessica E ^b   Duffy, Jeanne F ^b   Klerman, Elizabeth B ^b   Shanahan, Theresa L ^b   Dijk, Derk Jan ^b   Czeisler, Charles A ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Endocrine Hypertension Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

AGED; AGING; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSOMNIA; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINOLOGY; PINEAL BODY; PRIORITY JOURNAL; SLEEP WAKING CYCLE;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NASA PROGRAM BIOMEDICAL RESEARCH AND COUNTERMEASURES; NON-NASA CENTER;

ADULT; AGED; AGED, 80 AND OVER; AGING; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; SLEEP DISORDERS;

EID: 0033231366     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00266-1     Document Type: Article

References (56)

1. Grinevich Y.A., Labunetz I.F. Melatonin, thymic serum factor, and cortisol levels in healthy subjects of different age and patients with skin melanoma. J Pineal Res. 3:1986;263-275.
2. Touitou Y., Fevre-Montange M., Proust J., Klinger E., Nakache J.P. Age- and sex-associated modification of plasma melatonin concentrations in man. Relationship to pathology, malignant or not, and autopsy findings. Acta Endocrinol. 108:1985;135-144.
3. Waldhauser F., Weiszenbacher G., Tatzer E., et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab. 66:1988;648-652.
4. Cagnacci A., Soldani R., Yen S.S.C. Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. J Appl Physiol. 78:1995;314-317.
5. Carnazzo G., Paternó-Raddusa F., Travali S., Favetta A., Maugeri D., Stivala F. Variations of melatonin incretion in elderly patients affected by cerebral deterioration. Arch Gerontol Geriatr. S2:1991;123-126.
6. Claustrat B., Chazot G., Brun J., Jordan D., Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects plasma melatonin, a biochemical marker in major depression . Biol Psychiatry. 19:1984;1215-1228.
7. Ferrari E., Magri F., Locatelli M., et al. Chrono-neuroendocrine markers of the aging brain. Aging Clin Exp Res. 8:1996;320-327.
8. Klerman E.B., Shanahan T.L., Czeisler C.A. Differential changes in amplitude with aging in blind persons. Soc Res Biol Rhythms. 5:1996;131.
9. Lockley S.W., Skene D.J., Arendt J., Tabandeh H., Bird A.C., Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab. 82:1997;3763-3770.
10. Murialdo G., Costelli P., Fonzi S., et al. Circadian secretion of melatonin and thyrotropin in hospitalized aged patients. Aging Clin Exp Res. 5:1993;39-46.
11. Ohashi Y., Okamoto N., Uchida K., Iyo M., Mori N., Morita Y. Differential pattern of the circadian rhythm of serum melatonin in young and elderly healthy subjects. Biol Signals. 6:1997;301-306.
12. Touitou Y., Fèvre M., Bogdan A., et al. Patterns of plasma melatonin with ageing and mental condition stability of nyctohemeral rhythms and differences in seasonal variations . Acta Endocrinol. 106:1984;145-151.
13. Asplund R., Åberg H., Wetterberg L. Seasonal changes in the levels of antidiuretic hormone and melatonin in the elderly. J Pineal Res. 18:1995;154-158.
14. Wetterberg L., Aperia B., Gorelick D.A., et al. Age, alcoholism and depression are associated with low levels of urinary melatonin. J Psychiatr Neurosci. 17:1992;215-224.
15. Bojkowski C.J., Arendt J. Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin Endocrinol. 33:1990;435-444.
16. Brown G.M., Young S.N., Gauthier S., Tsui H., Grota L.J. Melatonin in human cerebrospinal fluid in daytime; its origin and variation with age. Life Sci. 25:1979;929-936.
17. Dori D., Casale G., Solerte S.B., et al. Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiologia. 21:1994;121-126.
18. Iguchi H., Kato K.-I., Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Metab. 55:1982;27-29.
19. Laughlin G.A., Morales A.J., Cagnacci A. Attenuation of the circadian rhythms of core body temperature and melatonin with aging in women. Endocrine Society Abstracts. 74:1992;251.
20. Magri F., Locatelli M., Balza G., et al. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging. Chronobiol Int. 14:1997;385-396.
21. Nair N.P.V., Hariharasubramanian N., Pilapil C. Circadian rhythm of plasma melatonin in endogenous depression. Prog Neuro-Psychopharmacol Biol Psychiat. 8:1984;715-718.
22. Nair N.P.V., Hariharasubramanian N., Pilapil C., Isaac I., Thavundayil J.X. Plasma melatonin - an index of brain aging in humans? Biol Psychiatry. 21:1986;141-150.
23. Pang S.F., Huang C.Y., Ng M.T. Age and plasma levels of melatonin and N-acetylserotonin in human beings. Neurosci Lett. 16:1984;S25.
24. Sack R.L., Lewy A.J., Erb D.L., Vollmer W.M., Singer C.M. Human melatonin production decreases with age. J Pineal Res. 3:1986;379-388.
25. Sharma M., Palacios-Bois J., Schwartz G., et al. Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry. 25:1989;305-319.
26. Thomas D.R., Miles A. Melatonin secretion and age. Biol Psychiatry. 25:1989;365-367.
27. Touitou Y. Some aspects of the circadian time structure in the elderly. Gerontology. 28:1982;53-67.
28. Touitou Y., Fèvre M., Lagoguey M., et al. Age-, and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J Endocrinol. 91:1981;467-475.
29. Van Coevorden A., Mockel J., Laurent E., et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol. 260:1991;E651-E661.
30. Young I.M., Francis P.L., Leone A.M., Stovell P., Silman R.E. Constant pineal output and increasing body mass account for declining melatonin levels during human growth and sexual maturation. J Pineal Res. 5:1988;71-85.
31. Kripke D.F., Elliott J.A., Youngstedt S.D., Smith J.S. Melatonin marvel or marker? Ann Med. 30:1998;81-87.
32. Ferrari E., Magri F., Dori D., et al. Neuroendocrine correlates of the aging brain in humans. Neuroendocrinology. 61:1995;464-470.
33. Haimov I., Laudon M., Zisapel N., et al. Sleep disorders and melatonin rhythms in elderly people. BMJ. 309:1994;167.
34. Skene D.J., Bojkowski C.J., Arendt J. Urinary 6-sulphatoxymelatonin excretion in breast cancer patients and control subjects. Fraschini F., Reiter R.J. Role of Melatonin and Pineal Peptides in Neuroimmunomodulation. 1991;301-305 Plenum Press, New York.
35. Nair N.P.V., Hariharasubramanian N., Pilapil C. Circadian rhythm of plasma melatonin and cortisol in endogenous depression. Brown G.M., Wainwright S.D. The Pineal Gland Endocrine Aspects . 1985;339-345 Pergamon Press, New York.
36. Birau N. Melatonin in human serum progress in screening investigation and clinic . Birau N., Schloot W. Melatonin Current Status and Perspectives . 1981;297-326 Pergamon Press, New York.
37. Ferrier I.N., Arendt J., Johnstone E.C., Crow T.J. Reduced nocturnal melatonin secretion in chronic schizophrenia relationship to body weight . Clin Endocrinol. 17:1982;181-187.
38. Shanahan T.L. Circadian Physiology and the Plasma Melatonin Rhythm in Humans [thesis]. 1995;Harvard University Medical School, Boston, MA.
39. Deacon S., Arendt J. Posture influences melatonin concentrations in plasma and saliva in humans. Neurosci Lett. 167:1994;191-194.
40. Deacon S.J., Arendt J., English J. Posture a possible masking factor of the melatonin circadian rhythm . Touitou Y., Arendt J., Pévet P. Melatonin and the Pineal Gland From Basic Science to Clinical Application . 1993;387-390 Elsevier Science Publishers, New York.
41. Mills J.N., Minors D.S., Waterhouse J.M. Adaptation to abrupt time shifts of the oscillator[s] controlling human circadian rhythms. J Physiol (Lond). 285:1978;455-470.
42. Czeisler C.A., Kronauer R.E., Allan J.S., et al. Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science. 244:1989;1328-1333.
43. Czeisler C.A., Johnson M.P., Duffy J.F., Brown E.N., Ronda J.M., Kronauer R.E. Exposure to bright light and darkness to treat physiologic maladaptation to night work. NEJM. 322:1990;1253-1259.
44. Hughes R.J., Sack R.L., Lewy A.J. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia assessment in a clinical trial of melatonin replacement . Sleep. 21:1998;52-68.
45. Collins SA. Systeme of Anatomy. London: Newcomb, 1685:1020-1021.
46. Kitay JI, Altschule MD. The Pineal Gland: A Review of the Physiologic Literature. Cambridge: Harvard University Press, 1954:77-78.
47. Kloeden P.E., Rössler R., Rössler O.E. Does a centralized clock for aging exist? Gerontology. 36:1990;314-322.
48. Reiter R.J. The pineal gland and melatonin in relation to aging a summary of the theories and of the data . Exp Gerontol. 30:1995;199-212.
49. Kloeden P.E., Rössler R., Rössler O.E. Timekeeping in genetically programmed aging. Exp Gerontol. 28:1993;109-118.
50. Murphy P.J., Myers B.L., Badia P. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav. 59:1996;133-139.
51. McIntyre I.M., Norman T.R., Burrows G.D., Armstrong S.M. Human melatonin suppression by light is intensity dependent. J Pineal Res. 6:1989;149-156.
52. Haimov I., Laudon M., Zisapel N., et al. The relationship between urinary 6-sulphatoxymelatonin rhythm and insomnia in old age. Adv Pineal Res. 8:1994;433-438.
53. Peirpaoli W., Regelson W. The Melatonin Miracle. 1995;Simon and Shuster, New York.
54. Williamson B.L., Tomlinson A.J., Mishra P.K., Gleich G.J., Naylor S. Structural characterization of contaminants found in commercial preparations of melatonin similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome . Chem Res Toxicol. 11:1998;234-240.
55. Borbély AA. Commentary on the articles by Arendt, Weaver, Mahle et al., and Guardiola-Lemat̂re. J Biol Rhythms 1997;12:707-708.
56. Avery D., Lenz M., Landis C. Guidelines for prescribing melatonin. Ann Med. 30:1998;122-130.